Dr Sara M. Tolaney Discusses the Role of Adjuvant Therapy in HER2-Positive Breast Cancer

Dr Tolaney on Standard Frontline Treatment Approaches in HER2+ Breast CancerПодробнее

Evaluating the Role of Neoadjuvant Endocrine Therapy in Breast CancerПодробнее

Optimizing HER2-Positive Breast Cancer Therapy: Balancing Efficacy and ToxicityПодробнее

Dr. Tolaney on Deescalating Therapy in Stage I HER2+ Breast CancerПодробнее

Dr. Tolaney on the Neoadjuvant Therapy for HER2-Positive Breast CancerПодробнее

Sara M. Tolaney, MD, MPH discusses the TAILORx studyПодробнее

Dr. Tolaney on the Evolution of Adjuvant Treatment for HER2+ Breast CancerПодробнее